The manufacturer of a breast cancer drug which has been deemed "too expensive" to be offered by the NHS has hit back at the decision.
Dr Jayson Dallas, general manager of Roche Products Limited, declared it "an incredible injustice."
Despite Roche offering a significant discount, we are once again disappointed that Nice has not shown any flexibility on access to Kadcyla.
Refusing patients access to this drug is an incredible injustice and tantamount to turning the clock back in cancer research and development. We plan to appeal this decision.
More top news
Heavy rain that has caused extensive flooding has left vehicles submerged and public transport severely disrupted in Aberdeen.
A slow start for most of us tomorrow with dribs and drabs of rain leaving some of us with a soggy journey into work.
The chief executive of one of the 'big six' energy companies tells ITV News a report customers are paying too much is a concern.